MedPath

Eposid

Brand Name: Eposid

Generic Name: Etoposide

Active
Registration Number

DRP-13185-01

Dosage Form

Solution for IV Injection

Issuance Date

January 31, 2023

Expiry Date

December 22, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mg/mL (50mg/2.5mL, 100mg/5mL and 200mg/10mL)
PackagingUSP Type I Clear Glass Vial (2.5mL, 5mL & 10mL net content) [Box of 1's]

Classification

C
Classification
Prescription Drug (Rx)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EtoposideActive
Monograph: Etoposide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform